Platelet-activating factor does not mediate circulatory failure induced by 35-GHz microwave heating

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 24, Issue 5, 2002, Pages 279-286

  Ryan, K L ^a   Jauchem, James R ^a   Tehrany, M R ^a   Boyle, H L ^a  

^a AIR FORCE RESEARCH LABORATORY   (United States)

Author keywords

Heatstroke; Hyperthermia; Platelet activating factor (PAF); Radiofrequency radiation

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; APAFANT; KETAMINE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; AZEPINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEATH; DRUG RECEPTOR BINDING; ELECTROCARDIOGRAM; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; HYPERTHERMIA; HYPOTENSION; IMMUNE RESPONSE; LUNG PARENCHYMA; MALE; MEAN ARTERIAL PRESSURE; MICROWAVE COOKING; NONHUMAN; ORGAN CIRCULATION; PATHOPHYSIOLOGY; RADIOFREQUENCY RADIATION; RAT; RECEPTOR BLOCKING; REGULATORY MECHANISM; SHOCK; SURVIVAL TIME; TEMPERATURE MEASUREMENT; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; FEVER; HEMODYNAMICS; METABOLISM; MICROWAVE RADIATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMAL; AZEPINES; FEVER; HEMODYNAMICS; HYPOTENSION; MALE; MICROWAVES; PLATELET ACTIVATING FACTOR; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, U.S. GOV'T, NON-P.H.S.; TRIAZOLES; ANIMALS; HEMODYNAMIC PROCESSES;

EID: 0035990674     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2002.24.5.802305     Document Type: Article

References (45)

1. Radio frequency radiation of millimeter wave length: Potential occupational safety issues relating to surface heating
2. Sustained 35-GHz radio frequency irradiation induces circulatory failure
3. Peripheral vascular responses to hyperthermia in the rat
4. Cardiorespiratory changes during microwave-induced lethal heat stress and β-adrenergic blockade
5. Splanchnic sympathetic nerve activity and circulating catecholamines in the hyperthermic rat
6. Circulatory responses to vasoconstrictor agents during passive heating in the rat
7. Effect of heating on the hemodynamic responses to vasoactive agents
8. Vascular reactivity and baroreflex function during hyperthermia in conscious rats
9. Effect of heating on vascular reactivity in rat mesenteric arteries
10. Responses of rat mesenteric arteries to norepinephrine during exposure to heat stress and acidosis
11. Effects of hyperthermia on contraction and dilatation of rabbit femoral arteries
12. Does nitric oxide mediate circulatory failure induced by 35-GHz microwave heating?
13. Circulatory failure induced by 35 GHz microwave heating: Effects of chronic nitric oxide synthesis inhibition
14. Mechanisms of circulatory ond intestinal barrier dysfunction during whole body hyperthermia
15. Nitric oxide does not contribute to the hypotension of heatstroke
16. Effect of nitric oxide synthase inhibition on regional blood flow during hyperthermia
17. Oxidative stress precedes circulatory failure induced by 35-GHz microwave heating
18. Platelet-activating factor and related lipid mediators
19. Role of platelet-activating factor in cardiovascular pathophysiology
20. Ptatelet activating factor and its role in trauma, shock, and sepsis
21. Platelet-activating factor (PAF) in experimental and clinical sepsis
22. Platelet-activating factor acetylhydrolases in health and disease
23. Platelet activating factor involvement in splanchnic artery occlusion shock in rats
24. TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against spltanchnic artery occlusion shock
25. Liver hyperthermia and oxidative stress: Role of iron and aldehyde production
26. Concentration-dependent effects of bradykinin on leukocyte recruitment and venular hemodynamics in rat mesentery
27. Altered platelet-activating factor levels and acetylhydrolase activities are associated with increasing severity of bronchopulmonary dysplasia
28. Evidence for endothelial cell activation/injury in heatstroke
29. Hyperthermia-induced changes in the vascular permeability of rats: A model system to examine therapeutic interventions
30. Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis
31. Evidence for a role of platelet activating factor in hypovolemic shock in the rat
32. Detection of platelet-activating factor during traumatic shock
33. Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PA F released in vitro from IgE sensitized basophils
34. Platelet activating factor interaction with tumor necrosis factor and myocardial depressant factor in splanchnic artery occlusion shock
35. Platelet-activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF receptor antagonist kadsurenome
36. Effect of SRI 63-675 on hemodynamics and blood PAF levels during porcine endotoxemia
37. The expression and localization of plasma platelet-activating factor acetylhydrolase in endotoxemic rats
38. Accumulation of platelet-activating factor acetylhydrolase in the peritoneal cavity of guinea pig after endotoxin shock
39. Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double-blind, placebo-controlled, multicenter clinical trial
40. Phase II multicenter clinical study of the platelet-activating factor receptor antagonist BB-882 in the treatment of sepsis
41. Effect of WEB 2086 on leukocyte adherence in response to hemorrhagic shock in rats
42. Effect of a platelet-activating factor antagonist. CV-3988, on different shock models in the rat
43. l in traumatic shock
44. A lethal role of platelet activating factor in anaphylactic shock in mice
45. Platelet-activating factor (Paf) antagonist. WEB 2086, protects against Paf-induced hypotension in Macaca fascicularis